PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR
Clinical trials for PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR explained in plain language.
Never miss a new study
Get alerted when new PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR trials appear
Sign up with your email to follow new studies for PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with tough cancers: first trial of targeted radiation therapy
Disease control Recruiting nowThis early-stage study aims to find a safe and effective dose of a targeted radiation drug for children and teenagers with specific cancers that have come back or stopped responding to standard treatments. The therapy delivers radiation directly to cancer cells. Researchers will …
Matched conditions: PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR
Phase: PHASE1 • Sponsor: ITM Solucin GmbH • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Simple blood test could predict deadly bone Cancer's return
Knowledge-focused Recruiting nowThis study is testing whether a blood test can predict if two types of bone cancer (Ewing sarcoma and osteosarcoma) will come back after treatment. Researchers will collect blood samples from about 340 patients aged 1 to 50 years old to look for tiny pieces of tumor DNA. The goal…
Matched conditions: PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC